Author: Keng, Choong-Tat; Choi, Yook-Wah; Welkers, Matthijs R.A.; Chan, Daphne Z.L.; Shen, Shuo; Gee Lim, Seng; Hong, Wanjin; Tan, Yee-Joo
Title: The human severe acute respiratory syndrome coronavirus (SARS-CoV) 8b protein is distinct from its counterpart in animal SARS-CoV and down-regulates the expression of the envelope protein in infected cells Cord-id: 9fe2rq9s Document date: 2006_10_10
ID: 9fe2rq9s
Snippet: The severe acute respiratory syndrome coronavirus (SARS-CoV), isolated from humans infected during the peak of epidemic, encodes two accessory proteins termed as 8a and 8b. Interestingly, the SARS-CoV isolated from animals contains an extra 29-nucleotide in this region such that these proteins are fused to become a single protein, 8ab. Here, we compared the cellular properties of the 8a, 8b and 8ab proteins by examining their cellular localizations and their abilities to interact with other SARS
Document: The severe acute respiratory syndrome coronavirus (SARS-CoV), isolated from humans infected during the peak of epidemic, encodes two accessory proteins termed as 8a and 8b. Interestingly, the SARS-CoV isolated from animals contains an extra 29-nucleotide in this region such that these proteins are fused to become a single protein, 8ab. Here, we compared the cellular properties of the 8a, 8b and 8ab proteins by examining their cellular localizations and their abilities to interact with other SARS-CoV proteins. These results may suggest that the conformations of 8a and 8b are different from 8ab although nearly all the amino acids in 8a and 8b are found in 8ab. In addition, the expression of the structural protein, envelope (E), was down-regulated by 8b but not 8a or 8ab. Consequently, E was not detectable in SARS-CoV-infected cells that were expressing high levels of 8b. These findings suggest that 8b may modulate viral replication and/or pathogenesis.
Search related documents:
Co phrase search for related documents- absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- absence presence and additional amino acid: 1, 2
- absence presence and long term storage: 1, 2
- absence presence and lysis buffer: 1, 2, 3, 4, 5
- accession number and acute respiratory syndrome: 1, 2, 3
- accession number and additional amino acid: 1
- accessory protein and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- acute respiratory syndrome and additional amino acid: 1
- acute respiratory syndrome and live guangdong market: 1
- acute respiratory syndrome and long term storage: 1, 2, 3, 4, 5
- acute respiratory syndrome and low molecular weight protein: 1
- acute respiratory syndrome and lysate present: 1
- acute respiratory syndrome and lysate protein: 1, 2, 3, 4
- acute respiratory syndrome and lysis buffer: 1, 2, 3
- lysate present and lysis buffer: 1
- lysate protein and lysis buffer: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date